Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Personnel topic
No spam. Unsubscribe anytime.
Regents approve extension for interim UC Davis Health CEO Michael Condren
Summary
The Health Services Committee voted to extend the appointment and compensation for Michael Condren as interim chief executive officer of UC Davis Health, effective Feb. 1, 2026, through December. The motion passed on a roll-call vote during the Jan. 7 open session.
The Health Services Committee voted to approve an extension of the appointment and compensation for Michael Condren as interim chief executive officer of UC Davis Health, effective Feb. 1, 2026, through December.
The vote came after a brief presentation of item H1 in which committee staff described the requested effective date and term. A regent moved the item and a second was recorded before the secretary conducted a roll-call vote; the chair announced that "Item H1 has been approved."
Committee materials presented the extension as an administrative personnel action to maintain executive leadership at UC Davis Health while the campus continues ongoing leadership and operational activities. Meeting participants did not discuss additional terms or compensation details in open session. The item was handled as an action and concluded with the formal roll-call acknowledgement of the outcome.
No further committee direction or formal amendments to the appointment were recorded in open session. The committee proceeded to the next discussion item on systemwide access to care.
